Cargando…
193. Standard of Care versus Alternative Beta-lactams for Treatment of Infections due to Serratia marcescens
BACKGROUND: The threat of inducible resistance and treatment failure positioned cefepime and carbapenems as the standard of care (SOC) treatment agents for infections due to AmpC-producing Enterobacterales regardless of antimicrobial susceptibility testing results. Recently published Infectious Dise...
Autores principales: | Green, Sarah B, Torrisi, Joseph, Advani, Shreena P, Albrecht, Benjamin, Jacob, Jesse T, Ashley Jones, Kayla, Kandiah, Sheetal, Paciullo, Kristen, Patel, Darshan, Patel, Manish, Satola, Sarah W, Suchindran, Sujit, Tam, Roland, Trible, Ronald, Vu, Trinh P, Witt, Lucy S, Howard-Anderson, Jessica, Babiker, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678013/ http://dx.doi.org/10.1093/ofid/ofad500.266 |
Ejemplares similares
-
193. Rapid Diagnostic Testing and Vancomycin Utilization for Contaminated Blood Cultures
por: Lockridge, Connor, et al.
Publicado: (2022) -
141. Evaluating Cefepime And Alternative Beta-lactams For The Treatment Of Serratia marcescens Blood Stream Infections
por: Vicente-Lopez, Natcha, et al.
Publicado: (2022) -
Serratia marcescens Endocarditis
por: Elkattawy, Sherif, et al.
Publicado: (2021) -
Etymologia: Serratia marcescens
por: Nazzaro, Gianluca
Publicado: (2019) -
Serratia marcescens: an outbreak experience
por: Gastmeier, Petra
Publicado: (2014)